BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17371237)

  • 1. Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?
    Geering B; Cutillas PR; Vanhaesebroeck B
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):199-203. PubMed ID: 17371237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of class IA PI3Ks.
    Wu H; Yan Y; Backer JM
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):242-4. PubMed ID: 17371249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New responsibilities for the PI3K regulatory subunit p85 alpha.
    Okkenhaug K; Vanhaesebroeck B
    Sci STKE; 2001 Jan; 2001(65):pe1. PubMed ID: 11752634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the inter-SH2 domain of the regulatory subunit of phosphoinositide 3-kinase: effects on catalytic subunit binding and holoenzyme function.
    Elis W; Lessmann E; Oelgeschlager M; Huber M
    Biol Chem; 2006 Dec; 387(12):1567-73. PubMed ID: 17132102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.
    Geering B; Cutillas PR; Nock G; Gharbi SI; Vanhaesebroeck B
    Proc Natl Acad Sci U S A; 2007 May; 104(19):7809-14. PubMed ID: 17470792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase.
    Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC
    Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms.
    Meier TI; Cook JA; Thomas JE; Radding JA; Horn C; Lingaraj T; Smith MC
    Protein Expr Purif; 2004 Jun; 35(2):218-24. PubMed ID: 15135396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice.
    Aoki K; Matsui J; Kubota N; Nakajima H; Iwamoto K; Takamoto I; Tsuji Y; Ohno A; Mori S; Tokuyama K; Murakami K; Asano T; Aizawa S; Tobe K; Kadowaki T; Terauchi Y
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E842-53. PubMed ID: 19176357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src-dependent association of Cas and p85 phosphatidylinositol 3'-kinase in v-crk-transformed cells.
    Riggins RB; DeBerry RM; Toosarvandani MD; Bouton AH
    Mol Cancer Res; 2003 Apr; 1(6):428-37. PubMed ID: 12692262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
    Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the p110 alpha isoform of PI3K in early development of mouse embryos.
    Xu XY; Zhang Z; Su WH; Zhang Y; Feng C; Zhao HM; Zong ZH; Cui C; Yu BZ
    Mol Reprod Dev; 2009 Apr; 76(4):389-98. PubMed ID: 18932194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH3 domain of the phosphatidylinositol 3-kinase regulatory subunit is responsible for the formation of a sequestration complex with insulin receptor substrate-1.
    Ikegami Y; Inukai K; Awata T; Asano T; Katayama S
    Biochem Biophys Res Commun; 2008 Jan; 365(3):433-8. PubMed ID: 17991427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of phosphatidylinositol 3-kinase: a potential second messenger system involved in growth control.
    Fry MJ; Waterfield MD
    Philos Trans R Soc Lond B Biol Sci; 1993 Jun; 340(1293):337-44. PubMed ID: 8103937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors.
    Katada T; Kurosu H; Okada T; Suzuki T; Tsujimoto N; Takasuga S; Kontani K; Hazeki O; Ui M
    Chem Phys Lipids; 1999 Apr; 98(1-2):79-86. PubMed ID: 10358930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras.
    Jimenez C; Hernandez C; Pimentel B; Carrera AC
    J Biol Chem; 2002 Nov; 277(44):41556-62. PubMed ID: 12196526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class IA PI3K regulatory subunits: p110-independent roles and structures.
    Fox M; Mott HR; Owen D
    Biochem Soc Trans; 2020 Aug; 48(4):1397-1417. PubMed ID: 32677674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Search for a molecular determinant in phosphatidylinositol-3-kinase molecules, involved in the interaction with the beta-gamma-G protein dimer].
    Shpakov AO
    Tsitologiia; 2002; 44(2):195-202. PubMed ID: 12053771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinol decreases phosphatidylinositol 3-kinase activity in colon cancer cells.
    Park EY; Wilder ET; Chipuk JE; Lane MA
    Mol Carcinog; 2008 Apr; 47(4):264-74. PubMed ID: 17918208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of phosphoinositide-3-kinase in mast cell homing to the gastrointestinal tract.
    Koyasu S; Minowa A; Terauchi Y; Kadowaki T; Matsuda S
    Novartis Found Symp; 2005; 271():152-61; discussion 161-5, 198-9. PubMed ID: 16605133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation.
    Dil N; Marshall AJ
    Mol Immunol; 2009 Jun; 46(10):1970-8. PubMed ID: 19362372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.